XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.200
0.00 (0.00%)
Sep 8, 2026, 11:33 AM EDT - Market open
XBiotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -45.13 | -45.54 | -38.53 | -24.56 | -32.9 | -17.41 |
Depreciation & Amortization | 1.44 | 1.69 | 1.75 | 1.74 | 2.61 | 2.65 |
Stock-Based Compensation | 0.53 | 3.62 | 1.75 | 3.26 | 5.06 | 4.46 |
Other Operating Activities | 2.58 | -3.33 | 5.53 | -1.89 | 2.8 | - |
Change in Accounts Receivable | - | - | - | - | - | 4.11 |
Change in Accounts Payable | -0.33 | -0.69 | -0.36 | 0.09 | 0.36 | -0.51 |
Change in Income Taxes | 0.2 | 0.31 | -0.11 | 0.6 | 8.71 | -2.17 |
Change in Other Net Operating Assets | 0.01 | 4.02 | -0.99 | 2.09 | -0.65 | 76.91 |
Operating Cash Flow | -40.7 | -39.92 | -30.96 | -18.73 | -14.82 | 69.45 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.14 | -0.29 | -1.3 | -0.36 | -0.59 | -3.53 |
Investment in Securities | - | - | - | 61.86 | -63.31 | - |
Investing Cash Flow | -0.14 | -0.29 | -1.3 | 61.5 | -63.89 | -3.53 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | 10.25 | - | - | - |
Total Debt Issued | - | - | 10.25 | - | - | - |
Short-Term Debt Repaid | - | -10.25 | - | - | - | - |
Total Debt Repaid | - | -10.25 | - | - | - | - |
Net Debt Issued (Repaid) | - | -10.25 | 10.25 | - | - | - |
Issuance of Common Stock | - | - | 0.2 | 0.01 | - | 8 |
Common Dividends Paid | - | - | - | - | - | -75 |
Other Financing Activities | - | - | - | -0.01 | - | - |
Financing Cash Flow | - | -10.25 | 10.45 | -0.01 | - | -67.01 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -2.58 | 3.33 | -5.53 | -0.05 | -0.96 | 0.71 |
Net Cash Flow | -43.41 | -47.13 | -27.35 | 42.72 | -79.68 | -0.38 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -40.84 | -40.21 | -32.27 | -19.09 | -15.41 | 65.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | -384.26% | 358.38% |
Free Cash Flow Per Share | -1.34 | -1.32 | -1.06 | -0.63 | -0.51 | 2.19 |
Levered Free Cash Flow | -28.5 | -26.28 | -26.29 | -16.1 | -6.33 | 66 |
Unlevered Free Cash Flow | -28.5 | -26.22 | -25.79 | -16.1 | -6.33 | 66 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | 0.49 | 0.4 | - | - | - |
Cash Income Tax Paid | - | -0.08 | 0.09 | 0.14 | - | - |
Change in Working Capital | -0.11 | 3.64 | -1.46 | 2.72 | 7.6 | 79.75 |